Global Cord Blood Corp
OTC:CORBF

Watchlist Manager
Global Cord Blood Corp Logo
Global Cord Blood Corp
OTC:CORBF
Watchlist
Price: 0.95 USD Market Closed
Market Cap: $127.2m

Wall St Price Targets

CORBF Price Targets Summary
Global Cord Blood Corp

There are no price targets for CORBF.
Lowest Forecast
Price Target
Not Available
Average Forecast
Price Target
Not Available
Highest Forecast
Price Target
Not Available
Global Cord Blood Corp Competitors:
Price Targets
SIGI
Selective Insurance Group Inc
14% Upside

Revenue
Forecast

13% / Year
Past Growth
-41% / Year
Estimated Growth
Estimates Accuracy
N/A
Average Beat/Miss
13% / Year
Past Growth
-41% / Year
Estimated Growth
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 14 years, the compound annual growth rate for Revenue has been 13%. The projected CAGR for the next 4 years is -41%.

Gross Profit
Forecast

14% / Year
Past Growth
-41% / Year
Estimated Growth
Estimates Accuracy
N/A
Average Beat/Miss
14% / Year
Past Growth
-41% / Year
Estimated Growth
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 14 years, the compound annual growth rate for Gross Profit has been 14%. The projected CAGR for the next 4 years is -41%.

Operating Income
Forecast

12% / Year
Past Growth
-46% / Year
Estimated Growth
Estimates Accuracy
N/A
Average Beat/Miss
12% / Year
Past Growth
-46% / Year
Estimated Growth
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 14 years, the compound annual growth rate for Operating Income has been 12%. The projected CAGR for the next 4 years is -46%.

Pre-Tax Income
Forecast

12% / Year
Past Growth
-45% / Year
Estimated Growth
Estimates Accuracy
N/A
Average Beat/Miss
12% / Year
Past Growth
-45% / Year
Estimated Growth
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 14 years, the compound annual growth rate for Pre-Tax Income has been 12%. The projected CAGR for the next 4 years is -45%.

Net Income
Forecast

13% / Year
Past Growth
-45% / Year
Estimated Growth
Estimates Accuracy
N/A
Average Beat/Miss
13% / Year
Past Growth
-45% / Year
Estimated Growth
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 14 years, the compound annual growth rate for Net Income has been 13%. The projected CAGR for the next 4 years is -45%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is CORBF's stock price target?
Not Available

CORBF does not have any price targets made by Wall Street professionals.

What is the Revenue forecast for Global Cord Blood Corp?
Projected CAGR
-41%

Over the last 14 years, the compound annual growth rate for Revenue has been 13%. The projected CAGR for the next 4 years is -41%.

What is the Gross Profit forecast for Global Cord Blood Corp?
Projected CAGR
-41%

Over the last 14 years, the compound annual growth rate for Gross Profit has been 14%. The projected CAGR for the next 4 years is -41%.

What is the Operating Income forecast for Global Cord Blood Corp?
Projected CAGR
-46%

Over the last 14 years, the compound annual growth rate for Operating Income has been 12%. The projected CAGR for the next 4 years is -46%.

What is the Pre-Tax Income forecast for Global Cord Blood Corp?
Projected CAGR
-45%

Over the last 14 years, the compound annual growth rate for Pre-Tax Income has been 12%. The projected CAGR for the next 4 years is -45%.

What is the Net Income forecast for Global Cord Blood Corp?
Projected CAGR
-45%

Over the last 14 years, the compound annual growth rate for Net Income has been 13%. The projected CAGR for the next 4 years is -45%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett